Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification

Mingying Wang,Haonan Li,Weiwei Liu,Hao Cao,Xu Hu,Xiang Gao,Fanxing Xu,Zhanlin Li,Huiming Hua,Dahong Li
DOI: https://doi.org/10.1016/j.ejmech.2020.112087
IF: 7.088
2020-03-01
European Journal of Medicinal Chemistry
Abstract:<p>Based on the definite therapeutic benefits, such as neuroprotective, cardioprotective, anticancer, anti-diabetic and so on, the <em>Panax</em> genus which contains many valuable plants, including ginseng (<em>Panax ginseng</em> C.A. Meyer), notoginseng (<em>Panax notoginseng</em>) and American ginseng (<em>Panax quinquefolius</em> L.), attracts research focus. Actually, the biological and pharmacological effects of the <em>Panax</em> genus are mainly attributed to the abundant ginsenosides. However, the low membrane permeability and the gastrointestinal tract influence seriously limit the absorption and bioavailability of ginsenosides. The acid or base hydrolysates of ginsenosides, 20 (<em>R</em>,<em>S</em>)-panaxadiol and 20 (<em>R</em>,<em>S</em>)-protopanaxadiol showed improved bioavailability and diverse pharmacological activities. Moreover, relative stable skeletons and active hydroxyl group at C-3 position and other reactive sites are suitable for structural modification to improve biological activities. In this review, the pharmacological activities of panaxadiol, protopanaxadiol and their structurally modified derivatives are comprehensively summarized.</p>
chemistry, medicinal
What problem does this paper attempt to address?